Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response.
Figl A
,
Viseshakul N
,
Shafaee N
,
Forsayeth J
,
Cohen BN
.
???displayArticle.abstract???
1. We constructed rat homologues (S252F and +L264) of two human alpha4 nicotinic mutations - alpha4(S248F) and alpha4(777ins3) - that have been linked to autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and co-expressed them with wild-type rat beta2 subunits in Xenopus oocytes. 2. The S252F and +L264 mutations had three common effects on the ACh response. First, they caused use-dependent potentiation of the response during a train of brief 100 nM ACh pulses. Second, they delayed the rise times of the 5-15 nM (+L264) and 30 nM (S252F) ACh responses. Third, they reduced extracellular Ca2+-induced increases in the 30 microM ACh response. 3. Beside these shared effects, the S252F mutation also reduced the channel burst duration measured from voltage-jump relaxations, enhanced steady-state desensitization and reduced the single-channel conductance. In contrast, the +L264 mutation prolonged the channel burst duration, did not affect desensitization and slightly increased single-channel conductance. Neither mutation affected the number of surface receptors measured by antibody binding but the S252F mutation reduced the maximum ACh response. 4. The ACh concentration dependence of use-dependent potentiation and the delay in the rising phase of the mutant ACh response suggest that these effects are caused by a slow unblocking of the closed mutant receptors. Use-dependent potentiation of the mutant response during a series of high-frequency cholinergic inputs to the presynaptic terminal could trigger ADNFLE seizures by suddenly increasing nicotinic-mediated transmitter release.
Adams,
Interaction of a fluorescent probe with acetylcholine-activated synaptic membrane.
1977, Pubmed
Adams,
Interaction of a fluorescent probe with acetylcholine-activated synaptic membrane.
1977,
Pubmed
Badio,
Epibatidine, a potent analgetic and nicotinic agonist.
1994,
Pubmed
Buisson,
Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.
1996,
Pubmed
Charnet,
Pharmacological and kinetic properties of alpha 4 beta 2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Clements,
Transmitter timecourse in the synaptic cleft: its role in central synaptic function.
1996,
Pubmed
Cohen,
Regions of beta 2 and beta 4 responsible for differences between the steady state dose-response relationships of the alpha 3 beta 2 and alpha 3 beta 4 neuronal nicotinic receptors.
1995,
Pubmed
,
Xenbase
Edmonds,
Mechanisms of activation of muscle nicotinic acetylcholine receptors and the time course of endplate currents.
1995,
Pubmed
Eilers,
Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism.
1997,
Pubmed
Figl,
Voltage-jump relaxation kinetics for wild-type and chimeric beta subunits of neuronal nicotinic receptors.
1996,
Pubmed
,
Xenbase
Flores,
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
1992,
Pubmed
Franke,
A molecular scheme for the reaction between acetylcholine and nicotinic channels.
1993,
Pubmed
Gerzanich,
Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
1995,
Pubmed
,
Xenbase
Houghtling,
Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
1995,
Pubmed
Ifune,
Inward rectification of acetylcholine-elicited currents in rat phaeochromocytoma cells.
1992,
Pubmed
Jobling,
Enhanced translation of chimaeric messenger RNAs containing a plant viral untranslated leader sequence.
,
Pubmed
KATZ,
A study of the desensitization produced by acetylcholine at the motor end-plate.
1957,
Pubmed
Karlin,
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.
1995,
Pubmed
Kuryatov,
Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors.
1997,
Pubmed
,
Xenbase
Lewis,
The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type.
1997,
Pubmed
,
Xenbase
Lopatin,
Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification.
1994,
Pubmed
,
Xenbase
Mulle,
Potentiation of nicotinic receptor response by external calcium in rat central neurons.
1992,
Pubmed
Peng,
Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
1994,
Pubmed
,
Xenbase
Sands,
Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes.
1993,
Pubmed
,
Xenbase
Scheffer,
Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder.
1995,
Pubmed
Shioda,
Nicotine increases cytosolic Ca2+ in vasopressin neurons.
1997,
Pubmed
Steinlein,
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
1995,
Pubmed
Steinlein,
An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy.
1997,
Pubmed
Vibat,
Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes.
1995,
Pubmed
,
Xenbase
Weiland,
An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics.
1996,
Pubmed
,
Xenbase
Whiting,
Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies.
1988,
Pubmed
Whiting,
Purification and characterization of a nicotinic acetylcholine receptor from rat brain.
1987,
Pubmed
Whiting,
Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts.
1991,
Pubmed
Wong,
Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells.
1995,
Pubmed
Wonnacott,
Presynaptic nicotinic ACh receptors.
1997,
Pubmed
Zagotta,
Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB.
1990,
Pubmed
,
Xenbase
